tm logo

Monitor this mark

View On USPTO

KYPROLIS
Live/Registered
REGISTERED AND RENEWED

on 11 Jul 2023

Last Applicant/ Owned by

Onyx Pharmaceuticals, Inc.

One Amgen Center Drive

Thousand Oaks

CA

913201799

Serial Number

85977958 filed on 08th Jul 2010

Registration Number

4269909 registered on 01st Jan 2013

in the Principal Register

Correspondent Address

Elsa D. Lemoine

Elsa D. Lemoine

One Amgen Center Drive

Trademarks Operations MS-28-5A

Thousand Oaks, CA 91320-1799

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

KYPROLIS

Human pharmaceuticals for use in the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Human pharmaceuticals for use in the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders

First Use Date in General

30th Jul 2012

First Use Date in Commerce

30th Jul 2012

Mark Details

Serial Number

No 85977958

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-1127-US-2

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
11th Jul 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11th Jul 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11th Jul 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07th Jul 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12th Dec 2022TEAS SECTION 8 & 9 RECEIVED
29th Apr 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29th Apr 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29th Apr 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
29th Apr 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
01st Jan 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED